701 related articles for article (PubMed ID: 10369824)
21. Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: A pilot study.
Purandare N; Oude Voshaar RC; Davidson Y; Gibbons L; Hardicre J; Byrne J; McCollum C; Jackson A; Burns A; Mann DM
J Am Geriatr Soc; 2006 Sep; 54(9):1395-400. PubMed ID: 16970648
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and clinical implication of microbleeds in dementia with lewy bodies in comparison with microbleeds in Alzheimer's disease.
Fukui T; Oowan Y; Yamazaki T; Kinno R
Dement Geriatr Cogn Dis Extra; 2013 Jan; 3(1):148-60. PubMed ID: 23741227
[TBL] [Abstract][Full Text] [Related]
23. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates.
Waldemar G; Christiansen P; Larsson HB; Høgh P; Laursen H; Lassen NA; Paulson OB
J Neurol Neurosurg Psychiatry; 1994 Dec; 57(12):1458-65. PubMed ID: 7798973
[TBL] [Abstract][Full Text] [Related]
24. Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction.
Hase Y; Polvikoski TM; Firbank MJ; Craggs LJL; Hawthorne E; Platten C; Stevenson W; Deramecourt V; Ballard C; Kenny RA; Perry RH; Ince P; Carare RO; Allan LM; Horsburgh K; Kalaria RN
Brain Pathol; 2020 Jan; 30(1):191-202. PubMed ID: 31357238
[TBL] [Abstract][Full Text] [Related]
25. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies.
Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; O'Brien JT
Neurology; 1999 Apr; 52(6):1153-8. PubMed ID: 10214736
[TBL] [Abstract][Full Text] [Related]
26. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison.
Chang YT; Chang CC; Lin HS; Huang CW; Chang WN; Lui CC; Lee CC; Lin YT; Chen CH; Chen NC
Acta Neurol Taiwan; 2012 Jun; 21(2):64-73. PubMed ID: 22879115
[TBL] [Abstract][Full Text] [Related]
27. White matter hyperintensities in dementia with Lewy bodies are associated with poorer cognitive function and higher dementia stages.
Chen TY; Chan PC; Tsai CF; Wei CY; Chiu PY
Front Aging Neurosci; 2022; 14():935652. PubMed ID: 36092817
[TBL] [Abstract][Full Text] [Related]
28. Impact of white matter changes on clinical manifestation of Alzheimer's disease: A quantitative study.
Hirono N; Kitagaki H; Kazui H; Hashimoto M; Mori E
Stroke; 2000 Sep; 31(9):2182-8. PubMed ID: 10978049
[TBL] [Abstract][Full Text] [Related]
29. Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study.
Ala TA; Yang KH; Sung JH; Frey WH
J Neurol Neurosurg Psychiatry; 1997 Jan; 62(1):16-21. PubMed ID: 9010394
[TBL] [Abstract][Full Text] [Related]
30. Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism.
Park HE; Park IS; Oh YS; Yang DW; Lee KS; Choi HS; Ahn KJ; Kim JS
J Neurol Sci; 2015; 353(1-2):44-8. PubMed ID: 25891829
[TBL] [Abstract][Full Text] [Related]
31. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.
Almeida OP; Burton EJ; McKeith I; Gholkar A; Burn D; O'Brien JT
Dement Geriatr Cogn Disord; 2003; 16(2):57-63. PubMed ID: 12784028
[TBL] [Abstract][Full Text] [Related]
32. [An autopsy case of dementia with Lewy bodies who showed the typical parkinsonism in the initial five years].
Kondo K; Miyashita K; Ogata J; Yutani C; Yamawaki T; Naritomi H
Nihon Ronen Igakkai Zasshi; 2000 Dec; 37(12):999-1003. PubMed ID: 11201192
[TBL] [Abstract][Full Text] [Related]
33. [Dementia with Lewy bodies].
Mori E
Nihon Ronen Igakkai Zasshi; 2000 Oct; 37(10):772-6. PubMed ID: 11215212
[TBL] [Abstract][Full Text] [Related]
34. White matter hyperintensities and the surrounding normal appearing white matter are associated with water channel disruption in the oldest old.
Silbert LC; Roese NE; Krajbich V; Hurworth J; Lahna D; Schwartz DL; Dodge HH; Woltjer RL
Alzheimers Dement; 2024 Jun; 20(6):3839-3851. PubMed ID: 38629888
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal relaxographic imaging of white matter hyperintensities in the elderly.
Anderson VC; Obayashi JT; Kaye JA; Quinn JF; Berryhill P; Riccelli LP; Peterson D; Rooney WD
Fluids Barriers CNS; 2014; 11():24. PubMed ID: 25379172
[TBL] [Abstract][Full Text] [Related]
36. [Neuropsychiatric features in Dementia with Lewy bodies and Alzheimer's disease].
Hirono N; Mori E; Imamura T; Shimomura T; Hashimoto M
No To Shinkei; 1998 Jan; 50(1):45-9. PubMed ID: 9493198
[TBL] [Abstract][Full Text] [Related]
37. Impacts of hyper-homocysteinemia and white matter hyper-intensity in Alzheimer's disease patients with normal creatinine: an MRI-based study with longitudinal follow-up.
Huang CW; Chang WN; Lui CC; Chen CF; Lu CH; Wang YL; Chen C; Juang YY; Lin YT; Tu MC; Chang CC
Curr Alzheimer Res; 2010 Sep; 7(6):527-33. PubMed ID: 20455861
[TBL] [Abstract][Full Text] [Related]
38. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression.
Nebes RD; Vora IJ; Meltzer CC; Fukui MB; Williams RL; Kamboh MI; Saxton J; Houck PR; DeKosky ST; Reynolds CF
Am J Psychiatry; 2001 Jun; 158(6):878-84. PubMed ID: 11384894
[TBL] [Abstract][Full Text] [Related]
39. White matter hyperintensities and chronicity of depression.
Heiden A; Kettenbach J; Fischer P; Schein B; Ba-Ssalamah A; Frey R; Naderi MM; Gulesserian T; Schmid D; Trattnig S; Imhof H; Kasper S
J Psychiatr Res; 2005 May; 39(3):285-93. PubMed ID: 15725427
[TBL] [Abstract][Full Text] [Related]
40. Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia.
Hirono N; Yasuda M; Tanimukai S; Kitagaki H; Mori E
Stroke; 2000 Jun; 31(6):1263-8. PubMed ID: 10835442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
